• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TALS

TALS

Talaris Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD2.72

-0.02 (-0.73%)

Company Profile

CEO

Mary Kay Fenton

IPO Date

2021-05-07

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.78

Prev. Close

$2.74

Day Low

$2.69

Day High

$2.79

52W Low

$0.89

52W High

$3.29

Market Cap

$0.12B

Volume

0.30M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

4

Avg Positive

26.0%

Avg Negative

1.5%

Avg Neutral

72.5%

News Feed

Talaris Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update

GlobeNewsWire·6/14/2021·↑ positive

Talaris Therapeutics Announces Closing of Initial Public Offering

GlobeNewsWire·5/11/2021·↑ positive

U.S. IPO Weekly Recap: Sacramento Bank Five Star Bancorp Finishes On Top In An 8 IPO Week

Seeking Alpha·5/8/2021·
↑ positive

Talaris Therapeutics Announces Pricing of Initial Public Offering

GlobeNewsWire·5/6/2021·↑ positive